Hormonstatus Frau — Female Hormone Panel

Female hormone assessment with AMH, LH, FSH, estradiol, progesterone, and TSH. At €128.23, includes AMH (anti-Müllerian hormone) for ovarian reserve assessment — a test that alone costs €50+ at most German labs.

This panel combines reproductive hormone assessment with ovarian reserve testing and thyroid screening. AMH (anti-Müllerian hormone) is the most reliable blood-based marker of ovarian reserve — reflecting the remaining pool of primordial follicles. AMH is increasingly requested by women considering future fertility, as it declines progressively with age and provides an objective measure of reproductive timeline. Unlike FSH and estradiol, AMH is relatively stable across the menstrual cycle, making it interpretable regardless of cycle day. FSH and LH are pituitary hormones that drive the menstrual cycle. Elevated FSH indicates diminished ovarian reserve or perimenopause. The LH:FSH ratio is diagnostically relevant in PCOS — a ratio above 2:1 supports the diagnosis alongside clinical and ultrasound criteria. Estradiol (the primary oestrogen) and progesterone provide information about ovarian function. Progesterone measured in the mid-luteal phase (day 21 of a 28-day cycle) confirms ovulation — progesterone above 10 nmol/L indicates a functional corpus luteum. TSH screens for thyroid dysfunction, which is 5–8 times more common in women and has significant reproductive consequences: hypothyroidism impairs ovulation, increases miscarriage risk, and affects foetal neurodevelopment. Thyroid screening is recommended before pregnancy and during early pregnancy. This panel provides the baseline data needed for fertility counselling, menstrual irregularity investigation, and perimenopause assessment.